Showing results (351-360 of 375) with videos related to

Sort By:
Pageof 38
Hellenic Journal of Nuclear Medicine|February 14, 2015
Feasibility and performance of an adaptive contrast-oriented FDG PET/CT quantification technique for global disease assessment of malignant pleural mesothelioma and a brief review of the literatureVictor A Marin-Oyaga, Ali Salavati, Sina Houshmand, et al.
RSC Advances|July 11, 2025
Convenient one-pot synthesis of 1-(4-(4-(2-[18F]fluoroethoxy)phenyl)piperazin-1-yl)ethanone ([18F]FEt-PPZ) for imaging tumors expressing sigma-1 receptorsSomnath Kar, Avik Chakraborty, Lakshminarayanan N, et al.
Langenbeck'S Archives of Surgery|May 22, 2023
Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumoursAmit Chopde, Amit Gupta, Vikram Chaudhari, et al.
Neuroendocrinology|October 5, 2020
Capecitabine-Temozolomide in Advanced Grade 2 and Grade 3 Neuroendocrine Neoplasms: Benefits of Chemotherapy in Neuroendocrine Neoplasms with Significant 18FDG UptakeVikas Ostwal, Sandip Basu, Prabhat Bhargava, et al.
Molecular Imaging and Biology|June 4, 2010
The effects of aging on testicular volume and glucose metabolism: an investigation with ultrasonography and FDG-PETHua Yang, Timothy Chryssikos, Mohamed Houseni, et al.
Indian Journal of Cancer|August 28, 2018
Surgical outcomes of thyroid cancer patients in a tertiary cancer center in IndiaAnuja Deshmukh, Kranthikumar Gangiti, Gouri Pantvaidya, et al.
Clinical Nuclear Medicine|October 26, 2023
68 Ga-PSMA-11 PET/CT Imaging in Brain Gliomas and Its Correlation With Clinicopathological Prognostic ParametersPriyanka Verma, Braj Kishore Singh, Manoharan Dwark Sudhan, et al.
Biomaterials|June 27, 2015
Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type IIJonathan M Page, Alyssa R Merkel, Nazanin S Ruppender, et al.
Data in Brief|August 26, 2015
Altering adsorbed proteins or cellular gene expression in bone-metastatic cancer cells affects PTHrP and Gli2 without altering cell growthJonathan M Page, Alyssa R Merkel, Nazanin S Ruppender, et al.
Journal of Neuro-Oncology|December 12, 2007
The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progressionMichael J Fisher, Sandip Basu, Eva Dombi, et al.
Pageof 38